SKI Market

A+| A| A-|

Indian Indices

Sensex

73,832.55 -150.63
( -0.20%)

Global Indices

Nasdaq

49,934.70 -958.41
(-1.88%)

Dow Jones

7,287.94 -119.71
(-1.62%)

Hang Seng

64,050.08 -129.19
(-0.20%)

Nikkei 225

10,254.58 27.25
(0.27%)

Forex

USD-INR

95.41 -0.12
(-0.12%)

EUR-INR

110.18 0.04
(0.03%)

GBP-INR

127.60 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

51.49

EPS(TTM)

Face Value()

Div & Yield %

Back

Kalpataru Projects International consolidated net profit rises 7.19% in the December 2025 quarter

Feb 04,2026

Net profit of Kalpataru Projects International rose 7.19% to Rs 152.17 crore in the quarter ended December 2025 as against Rs 141.96 crore during the previous quarter ended December 2024. Sales rose 16.27% to Rs 6665.42 crore in the quarter ended December 2025 as against Rs 5732.48 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6665.42	5732.48	16
OPM %	7.70	8.36	-
PBDT	404.55	325.12	24
PBT	276.97	202.02	37
NP	152.17	141.96	7

73,832.55 -150.63 ( -0.20%)

49,934.70 -958.41 (-1.88%)

7,287.94 -119.71 (-1.62%)

64,050.08 -129.19 (-0.20%)

10,254.58 27.25 (0.27%)

95.41 -0.12 (-0.12%)

110.18 0.04 (0.03%)

127.60 0.17 (0.13%)

0.60 0.00 (-0.17%)